• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Competing risks need to be considered in survival analysis models for cardiovascular outcomes.

作者信息

Huebner Marianne, Wolkewitz Martin, Enriquez-Sarano Maurice, Schumacher Martin

机构信息

Department of Statistics and Probability, Michigan State University, East Lansing, Mich.

Institute of Biometry and Medical Statistics, Medical Center, University of Freiburg, Freiburg, Germany.

出版信息

J Thorac Cardiovasc Surg. 2017 Jun;153(6):1427-1431. doi: 10.1016/j.jtcvs.2016.12.039. Epub 2017 Feb 3.

DOI:10.1016/j.jtcvs.2016.12.039
PMID:28526103
Abstract
摘要

相似文献

1
Competing risks need to be considered in survival analysis models for cardiovascular outcomes.在心血管疾病预后的生存分析模型中，需要考虑竞争风险。
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1427-1431. doi: 10.1016/j.jtcvs.2016.12.039. Epub 2017 Feb 3.
2
Mitral valve repair in asymptomatic patients with severe mitral regurgitation: pushing past the tipping point.无症状重度二尖瓣反流患者的二尖瓣修复：突破临界点。
Semin Thorac Cardiovasc Surg. 2014 Summer;26(2):95-101. doi: 10.1053/j.semtcvs.2014.07.004. Epub 2014 Jul 30.
3
Should we operate on asymptomatic patients with severe mitral regurgitation?我们应该对无症状的严重二尖瓣反流患者进行手术吗？
JACC Cardiovasc Imaging. 2008 Mar;1(2):142-4. doi: 10.1016/j.jcmg.2008.01.002.
4
eComment: Optimal management of severe asymptomatic mitral regurgitation.电子评论：重度无症状二尖瓣反流的最佳管理
Interact Cardiovasc Thorac Surg. 2010 Feb;10(2):305. doi: 10.1510/icvts.2009.225862A.
5
Valve repair for rheumatic mitral regurgitation: still worthwhile?风湿性二尖瓣反流的瓣膜修复：仍值得做吗？
J Heart Valve Dis. 2011 May;20(3):254-6.
6
Preoperative estimated glomerular filtration rate is an independent predictor of late cardiovascular morbidity after mitral valve surgery.术前估计肾小球滤过率是二尖瓣手术后晚期心血管疾病发病率的独立预测指标。
Ann Thorac Cardiovasc Surg. 2014;20(5):390-7. doi: 10.5761/atcs.oa.13-00187. Epub 2013 Nov 8.
7
[Mitral valve regurgitation in advanced heart failure: interventional or surgical treatment? For surgical treatment].晚期心力衰竭中的二尖瓣反流：介入治疗还是外科治疗？关于外科治疗
Dtsch Med Wochenschr. 2010 Apr;135(13):625. doi: 10.1055/s-0030-1251908. Epub 2010 Mar 23.
8
Survival of transcatheter mitral valve repair compared with surgical and conservative treatment in high-surgical-risk patients.高手术风险患者行经导管二尖瓣修复术与手术和保守治疗的生存比较。
JACC Cardiovasc Interv. 2014 Aug;7(8):875-81. doi: 10.1016/j.jcin.2014.01.171.
9
Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure.限制性二尖瓣环成形术可治愈缺血性二尖瓣反流和心力衰竭。
Ann Thorac Surg. 2008 Feb;85(2):430-6; discussion 436-7. doi: 10.1016/j.athoracsur.2007.08.040.
10
Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome.经皮二尖瓣修复术后残余二尖瓣反流是 MitraClip®系统治疗后一年不良结局的危险因素。
Catheter Cardiovasc Interv. 2013 Mar;81(4):609-17. doi: 10.1002/ccd.24586. Epub 2013 Feb 12.

引用本文的文献

1
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies.狼疮性肾炎与其他慢性肾脏病病因的长期预后比较。
Kidney Int Rep. 2024 Oct 28;10(1):157-168. doi: 10.1016/j.ekir.2024.10.021. eCollection 2025 Jan.
2
Assessment of Lifetime Risk for Cardiovascular Disease: Time to Move Forward.评估心血管疾病终生风险：是时候向前迈进了。
Curr Cardiol Rev. 2024;20(6):e030724231561. doi: 10.2174/011573403X311031240703080650.
3
The importance of considering competing risks in recurrence analysis of intracranial meningioma.
考虑颅内脑膜瘤复发分析中的竞争风险的重要性。
J Neurooncol. 2024 Feb;166(3):503-511. doi: 10.1007/s11060-024-04572-y. Epub 2024 Feb 10.
4
Dissemination of Registered COVID-19 Clinical Trials (DIRECCT): a cross-sectional study.新冠肺炎临床试验注册信息传播度（DIRECCT）：一项横断面研究。
BMC Med. 2023 Nov 29;21(1):475. doi: 10.1186/s12916-023-03161-6.
5
Incidence of Ischemic Stroke in Patients With Asymptomatic Severe Carotid Stenosis Without Surgical Intervention.无症状性重度颈动脉狭窄患者未行手术干预时的缺血性脑卒中发生率。
JAMA. 2022 May 24;327(20):1974-1982. doi: 10.1001/jama.2022.4835.
6
Results availability and timeliness of registered COVID-19 clinical trials: interim cross-sectional results from the DIRECCT study.已注册 COVID-19 临床试验的结果可获取性和及时性：DIRECTCT 研究的中期横断面结果。
BMJ Open. 2021 Nov 22;11(11):e053096. doi: 10.1136/bmjopen-2021-053096.
7
Long-term survival in patients with post-LVAD right ventricular failure: multi-state modelling with competing outcomes of heart transplant.LVAD 后右心室衰竭患者的长期生存：伴有心脏移植竞争结果的多状态模型。
J Heart Lung Transplant. 2021 Aug;40(8):778-785. doi: 10.1016/j.healun.2021.05.002. Epub 2021 May 19.
8
Late results after stand-alone surgical ablation for atrial fibrillation.孤立性手术消融治疗心房颤动的远期疗效。
J Thorac Cardiovasc Surg. 2022 Nov;164(5):1515-1528.e8. doi: 10.1016/j.jtcvs.2021.03.109. Epub 2021 Apr 17.
9
Efficacy of the stand-alone Cox-Maze IV procedure in patients with longstanding persistent atrial fibrillation.孤立性 Cox-Maze IV 手术治疗慢性持续性心房颤动的疗效。
J Cardiovasc Electrophysiol. 2021 Oct;32(10):2884-2894. doi: 10.1111/jce.15113. Epub 2021 Jun 10.
10
Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.观察性新型冠状病毒病 2019 药物疗效研究中偏倚的方法学评价。
Clin Microbiol Infect. 2021 Jul;27(7):949-957. doi: 10.1016/j.cmi.2021.03.003. Epub 2021 Apr 1.